Wilson Therapeutics
-
2012
Company Description
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases such as Wilson Disease. Wilson Therapeutics’ lead product, Decuprate, is initially being developed as a new treatment for Wilson Disease and is currently being evaluated in a Phase II clinical study in Wilson Disease patients.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Company Website:
-
Company E-mail:
-
Company Address:
Kungsgatan 3StockholmSweden -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits